The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Johnson-Léger, C.
Right arrow Articles by Klaus, G. G. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Johnson-Léger, C.
Right arrow Articles by Klaus, G. G. B.
The Journal of Immunology, 1998, 161: 4618-4626.
Copyright © 1998 by The American Association of Immunologists

Evidence for a Critical Role for IL-2 in CD40-Mediated Activation of Naive B Cells by Primary CD4 T Cells

Caroline Johnson-Léger, Jillian R. Christenson, Mary Holman and Gerry G. B. Klaus1

Division of Cellular Immunology, National Institute for Medical Research, London, United Kingdom

The interaction of CD40 on B cells with the CD40 ligand (CD40L) on preactivated CD4 T cells is critical for the initiation of T-dependent Ab responses. It is believed that signals via CD40 synergize with cytokines (e.g., IL-4 and IL-5) to drive B cell activation. However, primary T cells preactivated via CD3 alone cannot induce B cell proliferation; we have shown previously that costimulation of T cells via CD3 and CD28 stabilizes the expression of the CD40L, which we propose contributes to their capacity to act as competent helper-effector cells. Here we show that an additional, critical reason why CD3-stimulated CD40L-bearing T cells are incompetent helper cells is because they secrete insufficient IL-2. In contrast, CD28/CD3-activated T cells induce B cells to become IL-2 responsive via a combination of CD40L and IL-2-mediated signals, and these two stimuli subsequently drive B cell proliferation and IgM secretion. We therefore propose that T cells must first encounter Ag in conjunction with CD80/86 on APCs. This leads to the stable expression of CD40L and maximal secretion of IL-2, which together render primary T cells competent to activate B cells in an IL-2-dependent fashion.




This article has been cited by other articles:


Home page
J. Gen. Virol.Home page
P. Tsimbouri, Y. Al-Sheikh, M. E. Drotar, W. Cushley, and J. B. Wilson
Epstein-Barr virus nuclear antigen-1 renders lymphocytes responsive to IL-2 but not IL-15 for survival
J. Gen. Virol., November 1, 2008; 89(11): 2821 - 2832.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
I. Soeiro, A. Mohamedali, H. M. Romanska, N. C. Lea, E. S. Child, J. Glassford, S. J. Orr, C. Roberts, K. N. Naresh, E.-N. Lalani, et al.
p27Kip1 and p130 Cooperate To Regulate Hematopoietic Cell Proliferation In Vivo.
Mol. Cell. Biol., August 1, 2006; 26(16): 6170 - 6184.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
L. Bry, M. Brigl, and M. B. Brenner
CD4+-T-Cell Effector Functions and Costimulatory Requirements Essential for Surviving Mucosal Infection with Citrobacter rodentium
Infect. Immun., January 1, 2006; 74(1): 673 - 681.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Moir, K. M. Ogwaro, A. Malaspina, J. Vasquez, E. T. Donoghue, C. W. Hallahan, S. Liu, L. A. Ehler, M. A. Planta, S. Kottilil, et al.
Perturbations in B cell responsiveness to CD4+ T cell help in HIV-infected individuals
PNAS, May 13, 2003; 100(10): 6057 - 6062.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
B. O. Lee, L. Haynes, S. M. Eaton, S. L. Swain, and T. D. Randall
The Biological Outcome of CD40 Signaling Is Dependent on the Duration of CD40 Ligand Expression: Reciprocal Regulation by Interleukin (IL)-4 and IL-12
J. Exp. Med., September 2, 2002; 196(5): 693 - 704.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. G. Wingren, R. Hadzic, A. Forsgren, and K. Riesbeck
The Novel IgD Binding Protein from Moraxella catarrhalis Induces Human B Lymphocyte Activation and Ig Secretion in the Presence of Th2 Cytokines
J. Immunol., June 1, 2002; 168(11): 5582 - 5588.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
L. M. Plitnick, R. A. Jordan, J. A. Banas, D. M. Jelley-Gibbs, M. C. Walsh, M. T. Preissler, and E. J. Gosselin
Lipoteichoic Acid Inhibits Interleukin-2 (IL-2) Function by Direct Binding to IL-2
Clin. Vaccine Immunol., September 1, 2001; 8(5): 972 - 979.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
P. J. Blair, J. L. Riley, D. M. Harlan, R. Abe, D. K. Tadaki, S. C. Hoffmann, L. White, T. Francomano, S. J. Perfetto, A. D. Kirk, et al.
Cd40 Ligand (Cd154) Triggers a Short-Term Cd4+ T Cell Activation Response That Results in Secretion of Immunomodulatory Cytokines and Apoptosis
J. Exp. Med., February 21, 2000; 191(4): 651 - 660.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. W.-F. Lam, J. Glassford, L. Banerji, N. S. B. Thomas, P. Sicinski, and G. G. B. Klaus
Cyclin D3 Compensates for Loss of Cyclin D2 in Mouse B-lymphocytes Activated via the Antigen Receptor and CD40
J. Biol. Chem., February 4, 2000; 275(5): 3479 - 3484.
[Abstract] [Full Text] [PDF]


Home page
Hum Exp ToxicolHome page
H-A Kim, Y Heo, S-Y Oh, K-J Lee, and D A Lawrence
Altered serum cytokine and immunoglobulin levels in the workers exposed to antimony
Human and Experimental Toxicology, October 1, 1999; 18(10): 607 - 613.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
J. Glassford, M. Holman, L. Banerji, E. Clayton, G. G. B. Klaus, M. Turner, and E. W.-F. Lam
Vav Is Required for Cyclin D2 Induction and Proliferation of Mouse B Lymphocytes Activated via the Antigen Receptor
J. Biol. Chem., October 26, 2001; 276(44): 41040 - 41048.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.